In 2026, the Filibuster remains the most significant procedural obstacle to federal cannabis reform. While the executive branch is moving to Schedule III via administrative rulemaking, major legislative changes—like the SAFER Banking Act or full descheduling—continue to hit a wall in the U.S. Senate due to this rule